Showing results (161-170 of 211) with videos related to

Sort By:
Pageof 22
The Lancet. Global Health|July 8, 2024
Prevalence of all epilepsies in urban informal settlements in Nairobi, Kenya: a two-stage population-based studyDaniel M Mwanga, Damazo T Kadengye, Peter O Otieno, et al.
Trials|August 1, 2021
An Investigation of Levetiracetam in Alzheimer's Disease (ILiAD): a double-blind, placebo-controlled, randomised crossover proof of concept studyArjune Sen, Mary Akinola, Xin You Tai, et al.
Epilepsy & Behavior : E&B|October 11, 2025
Final analysis from an open-label extension study of fenfluramine for the treatment of seizures in Lennox-Gastaut syndrome: long-term impact on patients and caregiversKelly G Knupp, Ingrid E Scheffer, An-Sofie Schoonjans, et al.
Epilepsia|May 3, 2022
Methodology for classification and definition of epilepsy syndromes with list of syndromes: Report of the ILAE Task Force on Nosology and DefinitionsElaine C Wirrell, Rima Nabbout, Ingrid E Scheffer, et al.
Epilepsia|May 3, 2022
ILAE definition of the Idiopathic Generalized Epilepsy Syndromes: Position statement by the ILAE Task Force on Nosology and DefinitionsEdouard Hirsch, Jacqueline French, Ingrid E Scheffer, et al.
American Journal of Medical Genetics. Part A|September 27, 2021
Genomic analysis of "microphenotypes" in epilepsyKate Stanley, Joseph Hostyk, Linh Tran, et al.
Epilepsia|February 27, 2024
Genotype-phenotype associations in 1018 individuals with SCN1A-related epilepsiesDeclan Gallagher, Eduardo Pérez-Palma, Tobias Bruenger, et al.
The British Journal of Psychiatry : the Journal of Mental Science|November 20, 2025
Epilepsy and mental health disorders: current challenges and potential solutionsRiccardo De Giorgi, Tessa Lomax, Carmen Moreno, et al.
Brain : a Journal of Neurology|October 23, 2021
Early childhood epilepsies: epidemiology, classification, aetiology, and socio-economic determinantsJoseph D Symonds, Katherine S Elliott, Jay Shetty, et al.
Epilepsia Open|October 14, 2024
Safety, tolerability, and efficacy outcomes of the Investigation of Levetiracetam in Alzheimer's disease (ILiAD) study: a pilot, double-blind placebo-controlled crossover trialArjune Sen, Sofia Toniolo, Xin You Tai, et al.
Pageof 22